Jarrett S Gorlin insider trades: Medovex (MDVX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jarrett reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 19, 2017 | MDVX | ↑ Buy | 20,000 | $0.90 | $18K | Direct | Jun 20, 2017 (1d) |
| Jun 6, 2017 | MDVX | ↑ Buy | 25,000 | $0.91 | $23K | Direct | Jun 7, 2017 (1d) |
| Feb 9, 2017 | MDVX | ↑ Buy | 67,307 | $1.04 | $70K | Direct | Feb 14, 2017 (5d) |
| Apr 19, 2016 | MDVX | ↑ Buy | 44,081 | $1.23 | $54K | Direct | Apr 21, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jarrett S Gorlin's insider trades
Jarrett S Gorlin is Chief Executive Officer at Medovex (MDVX). Since Apr 19, 2016, Jarrett has reported 4 open-market purchases worth $165K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.